People channel feed

'What's he go­ing to do? He's go­ing to date his wife more!' Steve Holtz­man on Deci­bel and leav­ing biotech (again)

6 years ago

How do Amer­i­can sci­en­tists get em­broiled in Chi­na scan­dals? Mof­fitt in­ves­ti­ga­tion sheds some light

6 years ago
China

Lau­rence Reid re­turns as CEO of Deci­bel Ther­a­peu­tics — as Steve Holtz­man re­tires

6 years ago

Top Har­vard chemist caught up in FBI’s 'T­hou­sand Tal­ents' drag­net, ac­cused of ly­ing about Chi­nese con­nec­tions, pay

6 years ago
China

Eye­ing a trio of tri­al ini­ti­a­tions, Jim Wilson's gene ther­a­py start­up woos Bruce Gold­smith from Deer­field as CEO

6 years ago
Cell/Gene Tx

Mike Bloomberg joins a grow­ing cho­rus of De­mo­c­ra­t­ic pres­i­den­tial can­di­dates threat­en­ing to go af­ter drug patents

6 years ago
Pharma

Ex-No­var­tis CEO Joe Jimenez is tak­ing an­oth­er crack at open­ing a new chap­ter in his ca­reer — and that in­cludes a new board seat and a $250M start­up

6 years ago
Startups
R&D

The FTC and New York state ac­cuse Mar­tin Shkre­li of run­ning a drug mo­nop­oly. They plan to squash it — and per­ma­nent­ly ex­ile him

6 years ago
FDA+

Ku­ra co-founder heads to Asian mul­ti-na­tion­al as biotech eyes the goal posts for lead drug

6 years ago

'Y­ou be­trayed that du­ty': For­mer con­gress­man Chris Collins sen­tenced to 26 months in jail for in­sid­er trad­ing

6 years ago

Bernie Sanders goes af­ter Bio­Mar­in's shot at a record drug price, threat­en­ing to break the patent

6 years ago
Bioregnum
Pharma

Chi­na’s fourth rich­est man takes a back seat at the top drug­mak­er he built

6 years ago
China

#JPM20 ex­clu­sive: Olivi­er Brandi­court fol­lows the Big Phar­ma CEO path to pri­vate eq­ui­ty, join­ing Black­stone ahead of a mam­moth fund de­but

6 years ago
R&D

Cel­gene ex­ec jumps to head blue­bird bio ops in Eu­rope, where its $1.8M gene ther­a­py Zyn­te­glo is now avail­able

6 years ago

War­ren and Klobuchar say they can low­er drug prices with­out Con­gress’ help

6 years ago
Pharma

STUNG: Aduro CEO Stephen Isaacs reach­es for the bud­get ax — again — on the heels of their lat­est set­back with No­var­tis

6 years ago

Cred­i­bil­i­ty shred­ded, AM­AG jet­ti­sons CEO and 2 drugs as it looks to re­or­ga­nize around a sal­vage plan

6 years ago

Stan­ley and Rosanne Crooke stay fo­cused on an­ti-sense, steal­ing back pa­tients from dis­ease with N-of-1 tech

6 years ago
Startups
R&D

'Burn­er' phones and Ari­ad se­crets: Gold­man Sachs banker pleads guilty for his role in glob­al in­sid­er trad­ing ring

6 years ago
FDA+

Thomas Lynch finds a new home as leader of the Fred Hutch — and he’s stay­ing fo­cused on can­cer break­throughs

6 years ago
R&D

As in­vestors soured on his bets, records show Wood­ford paid him­self hand­some div­i­dends

6 years ago
Financing

'U snooze u lose': Judg­ment day for $100M biotech in­sid­er trad­ing scheme looms as son of for­mer Ari­ad di­rec­tor stands tri­al

6 years ago

As ques­tions swirl around lead drug, Fi­bro­Gen (and As­traZeneca) find a new cham­pi­on from Big Phar­ma

6 years ago
R&D

‘No one ex­pects to get a knight­hood’: As­traZeneca’s Mene Pan­ga­los knight­ed for his lead­ing role in UK life sci­ences

6 years ago
First page Previous page 71727374757677 Next page Last page
A service from the Financial Times